Effects of proinflammatory cytokines on canine articular chondrocytes in a three-dimensional culture

Am J Vet Res. 2005 Jul;66(7):1187-96. doi: 10.2460/ajvr.2005.66.1187.

Abstract

Objective: To determine the effects of interleukin (IL)-1 and tumor necrosis factor (TNF)-alpha on canine chondrocytes cultured in an agarose-based 3-dimensional (3-D) system.

Sample population: Humeral head articular cartilage chondrocytes obtained from 6 adult dogs.

Procedure: Chondrocytes were cultured in a 3-D system for < or = 12 days in serum-free medium with IL 1alpha, IL-1beta, or TNF-alpha at concentrations of 20, 50, or 100 ng/mL. After 1, 3, 6, and 12 days, glycosaminoglycan (GAG) concentrations in 3-D constructs; nitric oxide and prostaglandin E2 (PGE2) concentrations in media samples; and relative expressions of selected genes, including metalloproteinase (MMP)-13 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2, were evaluated. Control specimens were comprised of chondrocytes cultured without proinflammatory cytokines.

Results: In control 3-D constructs, GAG content was significantly higher than for all other constructs. Compared with control values, relative expressions of MMP-13, TIMP-1, and TIMP-2 genes in the IL-1beta (50 ng/mL) group were significantly higher at day 1; at all evaluations, media concentrations of nitric oxide were significantly higher in all TNF-alpha-treated cultures; and concentrations of PGE2 in media samples were significantly higher in the IL-1beta (50 ng/mL) and IL-1beta (100 ng/mL) groups at days 1 and 3, in the IL-1beta (100 ng/mL) group at day 6, and in all TNF-alpha groups at days 1, 3, and 6.

Conclusions and clinical relevance: Results suggested that TNF-alpha more readily induces production of nitric oxide and PGE2 by canine chondrocytes, compared with IL-1beta. In vitro, IL-1alpha appeared to have a minimal effect on canine chondrocytes.

MeSH terms

  • Aggrecans
  • Animals
  • Cartilage, Articular / cytology
  • Cartilage, Articular / drug effects
  • Cartilage, Articular / metabolism*
  • Cell Culture Techniques
  • Chondrocytes / drug effects
  • Chondrocytes / metabolism*
  • Collagen Type II / metabolism
  • Collagenases / metabolism
  • Dogs / metabolism*
  • Extracellular Matrix / metabolism
  • Extracellular Matrix Proteins / metabolism
  • Gene Expression / drug effects
  • Interleukin-1 / pharmacology
  • Interleukin-1 / physiology*
  • Lectins, C-Type
  • Matrix Metalloproteinase 1 / metabolism
  • Matrix Metalloproteinase 13
  • Proteoglycans / metabolism
  • Recombinant Proteins / pharmacology
  • Time Factors
  • Tissue Inhibitor of Metalloproteinase-1 / metabolism
  • Tissue Inhibitor of Metalloproteinase-2 / metabolism
  • Tumor Necrosis Factor-alpha / pharmacology
  • Tumor Necrosis Factor-alpha / physiology*

Substances

  • Aggrecans
  • Collagen Type II
  • Extracellular Matrix Proteins
  • Interleukin-1
  • Lectins, C-Type
  • Proteoglycans
  • Recombinant Proteins
  • Tissue Inhibitor of Metalloproteinase-1
  • Tumor Necrosis Factor-alpha
  • Tissue Inhibitor of Metalloproteinase-2
  • Collagenases
  • Matrix Metalloproteinase 13
  • Matrix Metalloproteinase 1